Invention Grant
- Patent Title: Uses of the human ZFX gene and drugs associated with same
- Patent Title (中): 使用人类ZFX基因和与之相关的药物
-
Application No.: US14239120Application Date: 2011-08-16
-
Publication No.: US09434949B2Publication Date: 2016-09-06
- Inventor: Yueqiong Cao , Dalong Lv , Xiangying Zhu , Haixiong Han , Honghua Qu , Yangsheng Jin
- Applicant: Yueqiong Cao , Dalong Lv , Xiangying Zhu , Haixiong Han , Honghua Qu , Yangsheng Jin
- Applicant Address: CN Shanghai
- Assignee: SHANGHAI GENECHEM CO., LTD.
- Current Assignee: SHANGHAI GENECHEM CO., LTD.
- Current Assignee Address: CN Shanghai
- Agency: Morrison & Foerster LLP
- International Application: PCT/CN2011/078482 WO 20110816
- International Announcement: WO2013/023361 WO 20130221
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/113 ; A61K45/06 ; A61K31/7105 ; A61K31/713

Abstract:
The present invention discloses uses of the human ZFX gene and drugs associated therewith. Also disclosed are uses of the human ZFX gene in tumor treatment, tumor diagnosis, and drug preparation. Further disclosed are small interfering RNA (siRNA), and nucleic acid and lentivirus encoding the siRNA to the human ZFX gene and uses thereof. The siRNA and nucleic acid and lentivirus encoding the siRNA provided by the present invention can specifically inhibit the expression of human ZFX gene. Lentiviruses in particular can efficiently infect target cells, inhibit ZFX expression in target cells, and inhibit the growth of tumor cells, thus promote tumor apoptosis and have great significance in tumor treatment.
Public/Granted literature
- US20140275219A1 USES OF THE HUMAN ZFX GENE AND DRUGS ASSOCIATED WITH SAME Public/Granted day:2014-09-18
Information query